Zenara

Hyderabad, India Founded: 2004 • Age: 22 yrs Acquired By Cambrex
Specialty contract development and manufacturing services are offered for pharmaceuticals.

About Zenara

Zenara is a Healthcare company based in Hyderabad (India) founded in 2004, and was acquired by Cambrex in November 2010. Specialty contract development and manufacturing services are offered for pharmaceuticals. The company has 231 employees. Its chief executive, as recorded, is Srinivas Arutla. Zenara offers products and services including Oral Solids, Liquids, and Parenteral Formulations. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity in India is Zenara Pharma India Private Limited (U24230MH2004PTC147284). Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.

Company details

Zenara was established in 2004 in Hyderabad, India, as a contract development and manufacturing organization within the pharmaceutical sector. Formulation development, manufacturing, and technology transfers for solid oral dosage forms are handled by the company. Nicotine Replacement Therapy products, such as medicated chewing gums and lozenges, are also developed and supplied. Operations are conducted as a wholly owned subsidiary of Cambrex, with a focus on regulatory services and licensing.

Key Metrics
  • Annual Revenue
    $4.99 M (USD)
    25
    as on Mar 31, 2022
  • Net Profit
    $373.13 K (USD)
    34
    as on Mar 31, 2022
  • EBITDA
    $664.1 K (USD)
    17
    as on Mar 31, 2022
  • Investors
  • Employee Count
    231
  • Acquired by
    Cambrex

    (Nov 2010)

Products & Services of Zenara

Zenara offers a comprehensive portfolio of products and services, including Oral Solids, Liquids, and Parenteral Formulations.

Oral Solids
Pharmaceutical Manufacturing

Produces solid medications for global distribution.

Liquids
Pharmaceutical Manufacturing

Manufactures liquid formulations for healthcare needs.

Parenteral Formulations
Pharmaceutical Manufacturing

Develops injectable drugs for medical applications.

Investors in Zenara

Zenara has secured backing from 1 investor. Prominent investors backing the company include Cambrex.

All
InvestorDescriptionFounded YearDomainLocation
CDMO of complex small molecule APIs, including highly potent APIs
1981cambrex.comEast Rutherford, United States
Premium access

Investor details for Zenara

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Zenara Pharma India Private Limited (Zenara)

Zenara Pharma India Private Limited is the primary company behind Zenara. The boards of the 2 registered companies of Zenara currently have 4 directors; the longest-serving is Rangaswamy Srinivasa Raghavan Gandarvakottai, appointed in 2007. 32 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rangaswamy Srinivasa Raghavan Gandarvakottai
DIN 01855204
Director29 Mar 200719 yrs 7 moZenara Pharma India Private Limited
Jaison Vazhakal Abraham
DIN 01817600
Director03 Mar 200818 yrs 8 moZenara Pharma India Private Limited
Manikreddy Pullagurla
DIN 01850939
Director21 Jan 20179 yrs 9 moZenara Pharma Private Limited
Jagadeesh Babu Rangisetty
DIN 01725762
Director21 Jan 20179 yrs 9 moZenara Pharma Private Limited

People of Zenara

1 people are tracked at Zenara (1 in leadership); the tracked headcount is 231.

NameRoleGroup
Srinivas Arutla
CEOLeadership
Premium access

Complete people profiles for Zenara

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Zenara

2 dated milestones of Zenara across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Zenara is founded.
  2. Exit Acquired by Cambrex.

Competitors of Zenara

Zenara has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inventiahealthcare.com1985Mumbai, India$42.49M980
Oral solid drug delivery systems are manufactured and developed.
zimlab.in1989Nagpur, India$8.2M598
Solid and semisolid dosage forms are developed and manufactured.
halewoodlabs.com1984Ahmedabad, India348
Provides contract manufacturing services for food, pharmaceuticals, and related products globally.
Premium access

Detailed competitors of Zenara

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Zenara (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zenara

Premium access

Complete news archive for Zenara

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zenara

Zenara was founded in 2004.

Zenara is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Srinivas Arutla is the CEO of Zenara, as recorded in our data.

Zenara has 231 employees.

Annual revenue of Zenara is $4.99M as on Mar 31, 2022.

Zenara was established in 2004 in Hyderabad, India, as a contract development and manufacturing organization within the pharmaceutical sector. Formulation development, manufacturing, and technology transfers for solid oral dosage forms are handled by the company. Nicotine Replacement Therapy products, such as medicated chewing gums and lozenges, are also developed and supplied. Operations are conducted as a wholly owned subsidiary of Cambrex, with a focus on regulatory services and licensing.

Zenara's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Zenara offers Oral Solids, Liquids, and Parenteral Formulations.

Zenara has 1 investor. Key investors include Cambrex.

Zenara is associated with 2 legal entities: Zenara Pharma India Private Limited, Zenara Pharma Private Limited.

Yes. Zenara was acquired by Cambrex in November 2010.

The legal entities of Zenara currently have 6 directors, including Rangaswamy Srinivasa Raghavan Gandarvakottai, Jaison Vazhakal Abraham, Manikreddy Pullagurla and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available